Johanna Olson-Kennedy1, Vivian Okonta2, Leslie F Clark3, Marvin Belzer3. 1. Division of Adolescent Medicine, Children's Hospital Los Angeles, Los Angeles, California; University of Southern California, Los Angeles, California. Electronic address: jolson@chla.usc.edu. 2. Division of Adolescent Medicine, Children's Hospital Los Angeles, Los Angeles, California. 3. Division of Adolescent Medicine, Children's Hospital Los Angeles, Los Angeles, California; University of Southern California, Los Angeles, California.
Abstract
PURPOSE: The purpose of this study was to examine the physiologic impact of hormones on youth with gender dysphoria. These data represent follow-up data in youth ages 12-23 years over a two-year time period of hormone administration. METHODS: This prospective, longitudinal study initially enrolled 101 youth with gender dysphoria at baseline from those presenting consecutively for care between February 2011 and June 2013. Physiologic data at baseline and follow-up were abstracted from medical charts. Data were analyzed by descriptive statistics. RESULTS: Of the initial 101 participants, 59 youth had follow-up physiologic data collected between 21 and 31 months after initiation of hormones available for analysis. Metabolic parameters changes were not clinically significant, with the exception of sex steroid levels, intended to be the target of intervention. CONCLUSIONS: Although the impact of hormones on some historically concerning physiologic parameters, including lipids, potassium, hemoglobin, and prolactin, were statistically significant, clinical significance was not observed. Hormone levels physiologically concordant with gender of identity were achieved with feminizing and masculinizing medication regimens. Extensive and frequent laboratory examination in transgender adolescents may be unnecessary. The use of hormones in transgender youth appears to be safe over a treatment course of approximately two years.
PURPOSE: The purpose of this study was to examine the physiologic impact of hormones on youth with gender dysphoria. These data represent follow-up data in youth ages 12-23 years over a two-year time period of hormone administration. METHODS: This prospective, longitudinal study initially enrolled 101 youth with gender dysphoria at baseline from those presenting consecutively for care between February 2011 and June 2013. Physiologic data at baseline and follow-up were abstracted from medical charts. Data were analyzed by descriptive statistics. RESULTS: Of the initial 101 participants, 59 youth had follow-up physiologic data collected between 21 and 31 months after initiation of hormones available for analysis. Metabolic parameters changes were not clinically significant, with the exception of sex steroid levels, intended to be the target of intervention. CONCLUSIONS: Although the impact of hormones on some historically concerning physiologic parameters, including lipids, potassium, hemoglobin, and prolactin, were statistically significant, clinical significance was not observed. Hormone levels physiologically concordant with gender of identity were achieved with feminizing and masculinizing medication regimens. Extensive and frequent laboratory examination in transgender adolescents may be unnecessary. The use of hormones in transgender youth appears to be safe over a treatment course of approximately two years.
Authors: Tiffany K Roberts; Colleen S Kraft; Deborah French; Wuyang Ji; Alan H B Wu; Vin Tangpricha; Corinne R Fantz Journal: Am J Med Date: 2013-10-19 Impact factor: 4.965
Authors: Henk Asscheman; Erik J Giltay; Jos A J Megens; W Pim de Ronde; Michael A A van Trotsenburg; Louis J G Gooren Journal: Eur J Endocrinol Date: 2011-01-25 Impact factor: 6.664
Authors: H Asscheman; G T'Sjoen; A Lemaire; M Mas; M C Meriggiola; A Mueller; A Kuhn; C Dhejne; N Morel-Journel; L J Gooren Journal: Andrologia Date: 2013-08-15 Impact factor: 2.775
Authors: Lisa M Wilson; Kellan E Baker; Ritu Sharma; Vadim Dukhanin; Kristen McArthur; Karen A Robinson Journal: Int J Transgend Health Date: 2020-09-17
Authors: Anna Valentine; Natalie Nokoff; Andrea Bonny; Gayathri Chelvakumar; Justin Indyk; Scott Leibowitz; Leena Nahata Journal: Transgend Health Date: 2021-12-02
Authors: Anna Valentine; Shanlee Davis; Anna Furniss; Nadia Dowshen; Anne E Kazak; Christopher Lewis; Danielle F Loeb; Leena Nahata; Laura Pyle; Lisa M Schilling; Gina M Sequeira; Natalie Nokoff Journal: J Clin Endocrinol Metab Date: 2022-09-28 Impact factor: 6.134
Authors: Johanna Olson-Kennedy; Yee-Ming Chan; Stephen Rosenthal; Marco A Hidalgo; Diane Chen; Leslie Clark; Diane Ehrensaft; Amy Tishelman; Robert Garofalo Journal: Transgend Health Date: 2019-11-01
Authors: Carl G Streed; Lauren B Beach; Billy A Caceres; Nadia L Dowshen; Kerrie L Moreau; Monica Mukherjee; Tonia Poteat; Asa Radix; Sari L Reisner; Vineeta Singh Journal: Circulation Date: 2021-07-08 Impact factor: 39.918
Authors: Marta R Bizic; Milos Jeftovic; Slavica Pusica; Borko Stojanovic; Dragana Duisin; Svetlana Vujovic; Vojin Rakic; Miroslav L Djordjevic Journal: Biomed Res Int Date: 2018-06-13 Impact factor: 3.411